Literature DB >> 26942728

[WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].

H Moch1.   

Abstract

The first S3 guidelines on renal cell cancer cover the practical aspects of imaging, diagnostics and therapy as well as the clinical relevance of pathology reporting. This review summarizes the changes in renal tumor classification and the new recommendations for reporting renal cell tumors. The S3 guidelines recommend the 2016 World Health Organization (WHO) classification of renal cell tumors. Novel renal cell tumor entities and provisional or emerging renal cell tumor entities of the 2016 WHO classification of renal tumors are discussed. The S3 guidelines for renal cell cancer also recommend the use of the WHO/International Society of Urologic Pathology (ISUP) grading system for clear cell and for papillary renal cell carcinomas, which replaces the previously used Fuhrman grading system.

Entities:  

Keywords:  Grading; Histopathology; Prognostic factors; TNM classification; WHO

Mesh:

Year:  2016        PMID: 26942728     DOI: 10.1007/s00292-016-0144-1

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  44 in total

1.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  Translocation carcinomas of the kidney after chemotherapy in childhood.

Authors:  Pedram Argani; Marick Laé; Edgar T Ballard; Mahul Amin; Carlos Manivel; Brian Hutchinson; Victor E Reuter; Marc Ladanyi
Journal:  J Clin Oncol       Date:  2006-04-01       Impact factor: 44.544

3.  Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Authors:  Satish K Tickoo; Mariza N dePeralta-Venturina; Lara R Harik; Heath D Worcester; Mohamed E Salama; Andrew N Young; Holger Moch; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

4.  Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinoma.

Authors:  Karl-Friedrich Deml; Hans-Ulrich Schildhaus; Eva Compérat; Adriana von Teichman; Martina Storz; Peter Schraml; Joseph V Bonventre; Falko Fend; Barbara Fleige; Andreas Nerlich; Helmut E Gabbert; Nikolaus GaBler; Rainer Grobholz; Seife Hailemariam; Raoul Hinze; Ruth Knüchel; Benoit Lhermitte; Gabriella Nesi; Thomas Rüdiger; Guido Sauter; Holger Moch
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

Review 5.  Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects.

Authors:  Naoto Kuroda; Chisato Ohe; Shuji Mikami; Keiji Inoue; Yoji Nagashima; Ronald J Cohen; Chin-Chen Pan; Michal Michal; Ondrej Hes
Journal:  Histol Histopathol       Date:  2012-08       Impact factor: 2.303

6.  Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR.

Authors:  Pedram Argani; Marick Laé; Brian Hutchinson; Victor E Reuter; Margaret H Collins; John Perentesis; John E Tomaszewski; John S J Brooks; Geza Acs; Julia A Bridge; Sara O Vargas; Ian J Davis; David E Fisher; Marc Ladanyi
Journal:  Am J Surg Pathol       Date:  2005-02       Impact factor: 6.394

7.  Tubulocystic carcinoma of the kidney: a new entity among renal tumors.

Authors:  Sandy Azoulay; Annick Vieillefond; François Paraf; Dominique Pasquier; Olivier Cussenot; Patrice Callard; Mathilde Sibony
Journal:  Virchows Arch       Date:  2007-09-05       Impact factor: 4.064

8.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

9.  Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term.

Authors:  Julia Turbiner; Mahul B Amin; Peter A Humphrey; John R Srigley; Laurence De Leval; Anuradha Radhakrishnan; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

10.  TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.

Authors:  A Ari Hakimi; Satish K Tickoo; Anders Jacobsen; James J Hsieh; Victor E Reuter; Judy Sarungbam; John P Sfakianos; Yusuke Sato; Teppei Morikawa; Haruki Kume; Masashi Fukayama; Yukio Homma; Ying-Bei Chen; Alexander Sankin; Roy Mano; Jonathan A Coleman; Paul Russo; Seishi Ogawa; Chris Sander
Journal:  Mod Pathol       Date:  2015-02-13       Impact factor: 7.842

View more
  2 in total

Review 1.  [Histological subtypes of renal cell carcinoma : Overview and new developments].

Authors:  I Polifka; A Agaimy; H Moch; A Hartmann
Journal:  Pathologe       Date:  2021-04-06       Impact factor: 1.011

Review 2.  Observations on Solitary Versus Multiple Isolated Pancreatic Metastases of Renal Cell Carcinoma: Another Indication of a Seed and Soil Mechanism?

Authors:  Franz Sellner
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.